Document de presse | 2023.11.23
Maternal-fetal listeriosis is a severe disease that can lead to miscarriage, premature birth or serious neonatal infection. But what are the long-term consequences of neonatal listeriosis on the health of surviving infants? For the first time, a team of scientists and physicians from the Institut Pasteur, Université Paris Cité, the Paris Public Hospital Network (AP-HP) and Inserm monitored the...
Document de presse | 2023.12.01
Nearly 39 million people worldwide are carriers of human immunodeficiency virus (HIV), and 1.3 million people contracted HIV in 2022[1]. Forty years after the virus was discovered at the Institut Pasteur, HIV research is still active – the aim is to elucidate the mechanisms of infection so that the virus can be eradicated. A concerted global effort has led to considerable progress in knowledge....
Document de presse | 2023.12.06
Researchers from the Institut de Parasitologie et de Pathologie Tropicale at the University of Strasbourg and the Laboratoire de Parasitologie et de Mycologie Médicale at the Strasbourg University Hospital, in collaboration with King's College London, UK, the Institut Pasteur (Paris, France), the Institut Pasteur de Madagascar and the University of Addis Ababa, Ethiopia, have revealed how...
Article | 2023.12.07
The Erasmus + Internships Programme gives the students at any study cycle and recent graduates of the University of Alicante the opportunity of undertaking a working experience in companies, institutions and organizations located in another country member of the EU.The project of Pasteur will address students at any study cycle and recent graduates of our Faculty of Sciences, detailed on...
Document de presse | 2023.12.05
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut Pasteur specialized in HIV, in collaboration with a French public research institute, the Alternative Energies and Atomic Energy Commission (CEA), conducted a study on lung...
News | 2023.12.11
A team from the Institut Pasteur in Paris, in collaboration with researchers in Spain, has identified Toscana virus in samples taken from patients in southern Spain. This virus is responsible for cases of encephalitis that have never been fully explained. The presence of this virus in the samples challenges the assumption that it was rare in the Mediterranean region. Thanks to this discovery,...
Document de presse | 2023.12.05
Scientists from Necker-Enfants Malades Hospital (AP-HP), the Institut Pasteur, Université Paris Cité, Inserm, Université Paris-Est Créteil and the Alfort National Veterinary School, coordinated by Professor Marc Eloit and Dr. Anne Jamet in collaboration with Dr. Jacques Fourgeaud and Beatrice Regnault, studied the role of global genetic characterization of samples (or non-targeted metagenomics)...
Document de presse | 2023.12.14
International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.The multidisciplinary European consortium MARVAX will receive 7.4 million euros over the next four years for the research and development of vaccines against Marburg viruses. Researchers from France, Spain and Germany will develop novel vaccine candidates, which...
News | 2023.12.19
Flaviviruses are pathogens transmitted by ticks that can cause serious diseases including neurological disorders. A study conducted at the Institut Pasteur reveals how these viruses can slip between the cracks of immunity.
News | 2023.12.20
To accelerate momentum in the global fight against hepatitis B, expanding testing and treatment services in resource-limited countries is crucial, especially in sub-Saharan Africa. But determining which patients are eligible for treatment is a complex process and requires tests that are not widely accessible in these regions. Should all people infected with the virus be treated without assessing...